drugset / Trial / NCT00021099

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

NCT00021099

Phase 2 Completed 45 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of ixabepilone in treating patients who have progressive or metastatic urinary tract cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
2001-06
Primary completion
2007-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous